Literature DB >> 23685408

Genetic characterization of SF3B1 mutations in single chronic lymphocytic leukemia cells.

X Wu1, R C Tschumper, D F Jelinek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23685408      PMCID： PMC4077158          DOI： 10.1038/leu.2013.155

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

Authors:  Davide Rossi; Alessio Bruscaggin; Valeria Spina; Silvia Rasi; Hossein Khiabanian; Monica Messina; Marco Fangazio; Tiziana Vaisitti; Sara Monti; Sabina Chiaretti; Anna Guarini; Ilaria Del Giudice; Michaela Cerri; Stefania Cresta; Clara Deambrogi; Ernesto Gargiulo; Valter Gattei; Francesco Forconi; Francesco Bertoni; Silvia Deaglio; Raul Rabadan; Laura Pasqualucci; Robin Foà; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

2.  Highly accurate analysis of heterozygous loci bysingle cell PCR.

Authors:  A M Garvin; W Holzgreve; S Hahn
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

3.  Spliceosome mutations in hematopoietic malignancies.

Authors:  Christopher N Hahn; Hamish S Scott
Journal:  Nat Genet       Date:  2011-12-27       Impact factor: 38.330

4.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

Authors:  Víctor Quesada; Laura Conde; Neus Villamor; Gonzalo R Ordóñez; Pedro Jares; Laia Bassaganyas; Andrew J Ramsay; Sílvia Beà; Magda Pinyol; Alejandra Martínez-Trillos; Mónica López-Guerra; Dolors Colomer; Alba Navarro; Tycho Baumann; Marta Aymerich; María Rozman; Julio Delgado; Eva Giné; Jesús M Hernández; Marcos González-Díaz; Diana A Puente; Gloria Velasco; José M P Freije; José M C Tubío; Romina Royo; Josep L Gelpí; Modesto Orozco; David G Pisano; Jorge Zamora; Miguel Vázquez; Alfonso Valencia; Heinz Himmelbauer; Mónica Bayés; Simon Heath; Marta Gut; Ivo Gut; Xavier Estivill; Armando López-Guillermo; Xose S Puente; Elías Campo; Carlos López-Otín
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

5.  Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Authors:  Luca Malcovati; Elli Papaemmanuil; David T Bowen; Jacqueline Boultwood; Matteo G Della Porta; Cristiana Pascutto; Erica Travaglino; Michael J Groves; Anna L Godfrey; Ilaria Ambaglio; Anna Gallì; Matteo C Da Vià; Simona Conte; Sudhir Tauro; Norene Keenan; Ann Hyslop; Jonathan Hinton; Laura J Mudie; James S Wainscoat; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Eva Hellström-Lindberg; Mario Cazzola
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

6.  Single-cell analysis of loss of heterozygosity at the ATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma: ATM loss of heterozygosity is a rare event.

Authors:  Virginie Lespinet; Fanny Terraz; Christian Recher; Elias Campo; Janet Hall; Georges Delsol; Talal Al Saati
Journal:  Int J Cancer       Date:  2005-05-10       Impact factor: 7.396

7.  Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Authors:  Yoshihiko Kotake; Koji Sagane; Takashi Owa; Yuko Mimori-Kiyosue; Hajime Shimizu; Mai Uesugi; Yasushi Ishihama; Masao Iwata; Yoshiharu Mizui
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

8.  Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

Authors:  E Papaemmanuil; M Cazzola; J Boultwood; L Malcovati; P Vyas; D Bowen; A Pellagatti; J S Wainscoat; E Hellstrom-Lindberg; C Gambacorti-Passerini; A L Godfrey; I Rapado; A Cvejic; R Rance; C McGee; P Ellis; L J Mudie; P J Stephens; S McLaren; C E Massie; P S Tarpey; I Varela; S Nik-Zainal; H R Davies; A Shlien; D Jones; K Raine; J Hinton; A P Butler; J W Teague; E J Baxter; J Score; A Galli; M G Della Porta; E Travaglino; M Groves; S Tauro; N C Munshi; K C Anderson; A El-Naggar; A Fischer; V Mustonen; A J Warren; N C P Cross; A R Green; P A Futreal; M R Stratton; P J Campbell
Journal:  N Engl J Med       Date:  2011-09-26       Impact factor: 91.245

9.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer.

Authors:  Simon A Forbes; Nidhi Bindal; Sally Bamford; Charlotte Cole; Chai Yin Kok; David Beare; Mingming Jia; Rebecca Shepherd; Kenric Leung; Andrew Menzies; Jon W Teague; Peter J Campbell; Michael R Stratton; P Andrew Futreal
Journal:  Nucleic Acids Res       Date:  2010-10-15       Impact factor: 16.971

10.  Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia.

Authors:  M Schwaederlé; E Ghia; L Z Rassenti; M Obara; M L Dell'Aquila; J F Fecteau; T J Kipps
Journal:  Leukemia       Date:  2013-01-22       Impact factor: 11.528
View more
  5 in total

Review 1.  Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.

Authors:  Jermaine L Jenkins; Clara L Kielkopf
Journal:  Trends Genet       Date:  2017-03-31       Impact factor: 11.639

2.  Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.

Authors:  Manoj K Kashyap; Deepak Kumar; Reymundo Villa; James J La Clair; Chris Benner; Roman Sasik; Harrison Jones; Emanuela M Ghia; Laura Z Rassenti; Thomas J Kipps; Michael D Burkart; Januario E Castro
Journal:  Haematologica       Date:  2015-04-10       Impact factor: 9.941

3.  The impact of SF3B1 mutations in CLL on the DNA-damage response.

Authors:  G D Te Raa; I A M Derks; V Navrkalova; A Skowronska; P D Moerland; J van Laar; C Oldreive; H Monsuur; M Trbusek; J Malcikova; M Lodén; C H Geisler; J Hüllein; A Jethwa; T Zenz; S Pospisilova; T Stankovic; M H J van Oers; A P Kater; E Eldering
Journal:  Leukemia       Date:  2014-11-05       Impact factor: 11.528

4.  The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia.

Authors:  Sílvia Xargay-Torrent; Mónica López-Guerra; Laia Rosich; Arnau Montraveta; Jocabed Roldán; Vanina Rodríguez; Neus Villamor; Marta Aymerich; Chandraiah Lagisetti; Thomas R Webb; Carlos López-Otín; Elias Campo; Dolors Colomer
Journal:  Oncotarget       Date:  2015-09-08

5.  Multi-genic pattern found in rare type of hypopituitarism: a whole-exome sequencing study of Han Chinese with pituitary stalk interruption syndrome.

Authors:  Qing-Hua Guo; Cheng-Zhi Wang; Zhi-Qiang Wu; Yan Qin; Bai-Yu Han; An-Ping Wang; Bao-An Wang; Jing-Tao Dou; Xiao-Sheng Wu; Yi-Ming Mu
Journal:  J Cell Mol Med       Date:  2017-07-14       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.